Alcon said the Aerie deal is another example of its strategy to expand in the ophthalmic pharmaceutical eye drop space. "Aerie is a natural fit with on-market and pipeline products, and R&D ...

Novartis’ long-awaited separation from its eye care division Alcon completed on schedule today, allowing it to focus its energies on medicinal products. Alcon’s shares made their debut on the ...

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and ...

Alcon (ALC) Company Description: Alcon Inc. is a medical company which is specialized in eye care products. The company develops, manufactures, distributes, and sells technologies and devices for ...

Vision Care Returns to Growth: Within Vision Care, Alcon is registering solid growth, banking on strong sales of its contact lenses and ocular health products ... portfolio of eye drops, including ...

Alcon, the global leader in eye care, has developed a platform for ... The partnership’s goal is to further develop the product to improve its performance and capabilities, and thus enable ...

Edetate disodium (EDTA) is a chelating agent used in a variety of nonophthalmic products, including hair ... [19] EDTA has also been used in eye washes to aid in neutralization of calcium ...

Alcon ALC has been gaining from a strong pipeline and its focus on research and innovation. Market share gains also aid growth. The stock currently carries a Zacks Rank #2 (Buy). In Presbyopia ...

Investor meetings in Chicago with Alcon's VP of Investor Relations, Dan Cravens, and Director of Investor Relations, Allen Trang, revealed insights into the company's market dynamics and product ...